Note: Ingredients listed on restricted chemical lists
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
N/A
General Information
Revision date
2021-07-23
Product name
MEPRON SUSPENSION
Product Synonyms
MEPRON ORAL SUSPENSION 750 MG/5 ML * WELLVONE ORAL SUSPENSION 750 MG/5 ML *
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1B
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 1
2.2 Label elements
Hazard symbol(s)
Signal word
Warning
Hazard statements
May cause an allergic skin reaction. Very toxic to aquatic life. Very toxic to aquatic life with long lasting effects.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of soap and water. If skin irritation or rash occurs Get medical advice/attention. Wash contaminated clothing before reuse. Collect spillage.
Disposal
Dispose of contents/container (in accordance with related regulations). 2.3 Other hazards which do not Expected to be non-combustible. result in GHS classification Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
16 % of the mixture consists of component(s) of unknown acute dermal toxicity.
